USE OF 177LU-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER




Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer

In patients with RAS wild-type metastatic colorectal cancer (mCRC), an anti-epidermal growth factor receptor (EGFR) monoclonal antibody plus chemotherapy is a Stove Burner Cap standard option for treatment in the first-line setting.Patients who progress while on treatment with anti-EGFR-based therapy can be resistant to further anti-EGFR treatment,

read more

Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)

Abstract Background Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility.Other RCTs are discontinued early because of insufficient recruitment.Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committ

read more